Holen Sie sich die Stockscreener-App
4.71
3.97%
0.18
Schlusskurs vom Vortag:
$4.53
Offen:
$4.51
24-Stunden-Volumen:
86,404
Relative Volume:
1.03
Marktkapitalisierung:
$141.54M
Einnahmen:
$8.98M
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-3.5149
EPS:
-1.34
Netto-Cashflow:
$-24.83M
1W Leistung:
+1.73%
1M Leistung:
-0.21%
6M Leistung:
-41.20%
1J Leistung:
-44.49%
1-Tages-Spanne:
$4.50
$4.9618
1-Wochen-Bereich:
$4.01
$4.9618
52-Wochen-Spanne:
$3.895
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Vergleichen Sie PROF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
4.71 | 139.15M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Lake Street | Buy |
| 2024-07-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-11-28 | Eingeleitet | Stifel | Hold |
| 2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
Objective long/short (PRN) Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch - MSN
Profound Medical announces shareholder vote results By Investing.com - Investing.com Nigeria
Profound Medical announces shareholder vote results - Investing.com
Profound Medical Corp. Announces Successful Shareholder Meeting Outcomes - TipRanks
Profound Medical Annual General and Special Meeting of Shareholders Voting Results | PROF Stock News - GuruFocus
Profound Medical Annual General and Special Meeting of Shareholders Voting Results - The Manila Times
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - news.stocktradersdaily.com
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript - Insider Monkey
Profound Medical stock rating downgraded at Raymond James By Investing.com - Investing.com Nigeria
Profound Medical stock rating downgraded at Raymond James - Investing.com
Profound Medical (PROF) Downgraded by Raymond James Amid Economic Concerns | PROF Stock News - GuruFocus
Profound Medical Q1 2025 revenue jumps 82% - Medical Buyer
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... By GuruFocus - Investing.com Canada
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Earnings call transcript: Profound Medical Q1 2025 sees revenue surge - Investing.com
Profound Medical Q1 2025 Earnings Call Transcript - MarketBeat
Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Profound Medical Corp. Q1 Loss Increases, Misses Estimates - Nasdaq
Profound Medical Reports Strong Q1 2025 Growth and Highlights TULSA-PRO Advancements - TipRanks
Profound Medical Announces First Quarter 2025 Financial Results - The Manila Times
Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
(PRN) Dynamic Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Corp expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? - Yahoo Finance
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Strong week for Profound Medical (TSE:PRN) shareholders doesn't alleviate pain of five-year loss - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Profound Medical: In Serious Trouble Despite Projected Growth (NASDAQ:PROF) - Seeking Alpha
Profound Medical to Present at 2025 Healthcare Investor Conference - TipRanks
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times
XTX Topco Ltd Buys New Position in Profound Medical Corp. (NASDAQ:PROF) - Defense World
Is Profound Medical a buy right now? - Cantech Letter
Toronto Stocks Flat as Liberals Clinch Fourth Term Government; Profound Medical Shares Up - marketscreener.com
Profound Medical (PROF) Showcases Promising TULSA Procedure Resu - GuruFocus
Stocks in play: Profound Medical Corp. - Barchart.com
Profound Medical Corp. - Baystreet.ca
Profound Medical Announces Positive CAPTAIN Trial Results - TipRanks
Profound Medical (PROF) Showcases Promising TULSA Procedure Results in Prostate Cancer Trial | PROF Stock News - GuruFocus
Profound Medical Brief: Says Provides "Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy" - marketscreener.com
Profound Medical Brief: Detailing Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA - marketscreener.com
Profound Medical Highlights TULSA-PRO at Urology Meeting - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - PR Newswire
Bank of Montreal Can Decreases Stake in Profound Medical Corp. (NASDAQ:PROF) - Defense World
(PRN) Investment Report (PRN:CA) - news.stocktradersdaily.com
Lake Street Capital Cuts Profound Medical (NASDAQ:PROF) Price Target to $11.00 - Defense World
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Price Target Cut Ahead of Study Release - GuruFocus
Profound Medical (PROF) Price Target Cut Ahead of Study Release | PROF Stock News - GuruFocus
Profound Medical announces annual meeting details By Investing.com - Investing.com India
Profound Medical announces annual meeting details - Investing.com
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):